“…Most of these proteins fall in one of the following five categories: hormones (eg, human insulin, human growth hormone, calcitonin, somatostatin, relaxin, parahormone, erythropoietin), immunomodulators (eg, interferones, interieukines, colony-stimulating factors), blood products (eg, tissue plasminogen activator, factor VIII, factor IX, human serum albumin, alpha-Iantitrypsin), antitumor agents (tumor necrosis factor, immunotoxins), and vaccines (hepatitis B) (1,(13)(14)(15). Future developments, apart from an increase in the number of protein products, will probably show a spread of rDNA technology to many other areas, such as the synthesis of nonprotein compounds through the construction of whole pathways in living organisms (16), the production of nonprotein biopolymers (17), and the catalysis of specific reactions such as bioleaching in mineral processing (18). These applications are, however, very much at the experimental stage at the moment and have not been considered in this review; instead it is systems for the industrial production of peptides and proteins that have been included.…”